Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL7086757

CC(C)(C)c1cc([O-])cc(C(C)(C)C)c1.O=S(=O)([O-])C(F)(F)F.O=S(=O)([O-])C(F)(F)F.[Al+3]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 2/20 0.38
GABRA1 P14867 1/20 0.35
GABRB2 P47870 1/20 0.35
ALDH1A1 P00352 2/20 0.34
ACHE P22303 4/20 0.32
NR1I2 O75469 1/20 0.31
PTPN1 P18031 1/20 0.31
S1PR1 P21453 1/20 0.31
FFAR1 O14842 1/20 0.31
FFAR4 Q5NUL3 1/20 0.31
KCNH2 Q12809 4/20 0.30
ACLY P53396 1/20 0.30
RORA P35398 1/20 0.30
HSD11B1 P28845 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL7213150 0.89 ACHE (0.40) GPR3ALDH1A1ACHEPTPN1KCNH2
Trifluoromethanesulfonic Acid SCHEMBL7089707 0.87 GABRA1 (0.39) GABRA1GABRB2ALDH1A1ACHEPTPN1
Trifluoromethanesulfonic Acid SCHEMBL7089713 0.82 ACHE (0.42) GPR3ALDH1A1ACHENR1I2PTPN1
Trifluoromethanesulfonic Acid SCHEMBL31447261 0.79 GABRA1 (0.34) GPR3GABRA1GABRB2ALDH1A1ACHE
SCHEMBL5702852 0.76 GABRA1 (0.50) GABRA1GABRB2ALDH1A1
Potassium Ion SCHEMBL7743976 0.76 GABRA1 (0.50) GABRA1GABRB2ALDH1A1
SCHEMBL7738539 0.76 GABRA1 (0.50) GABRA1GABRB2ALDH1A1
Lithium Ion SCHEMBL7743757 0.76 GABRA1 (0.50) GABRA1GABRB2ALDH1A1
Trifluoromethanesulfonic Acid SCHEMBL8719844 0.74 ACHE (0.33) GPR3ALDH1A1ACHEPTPN1KCNH2
Hydrochloric Acid SCHEMBL6040026 0.74 GABRA1 (0.48) GABRA1GABRB2ALDH1A1S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6624321-B2 Metathesis ring-opening polymerization of cyclic ethers in the presence of catalysts such as aluminum bis(trifluoromethane-sulfonate) phenolate BAYER AKTIENGESELLSCHAFT (DE) 2003-09-23 US disclosed
US-20030097026-A1 Process for the preparation of polyether polyols DENNINGER UWE (DE) 2003-05-22 US disclosed
US-6492565-B2 USING ALKYLENE OXIDE IN PRESENCE OF LEWIS ACID CATALYST BAYER AKTIENGESELLSCHAFT (DE) 2002-12-10 US disclosed
US-20010053866-A1 Process for the preparation of polyether polyols BAYER AKTIENGESELLSCHAFT (DE) 2001-12-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030097026-A1 Process for the preparation of polyether polyols PCBP1, FHIT, PUF60 GPR3 3548/4885GABRA1 669/4885GABRB2 1218/4885
US-20010053866-A1 Process for the preparation of polyether polyols PCBP1, FHIT, PUF60 GPR3 3548/4885GABRA1 669/4885GABRB2 1218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.